Be. Price et al., ANTIPHOSPHOLIPID AUTOANTIBODIES BIND TO APOPTOTIC, BUT NOT VIABLE, THYMOCYTES IN A BETA(2)-GLYCOPROTEIN I-DEPENDENT MANNER, The Journal of immunology, 157(5), 1996, pp. 2201-2208
Anti-phospholipid autoantibodies (aPL) are associated with a clinical
syndrome of hypercoagulability, thrombocytopenia, and fetal loss. Seve
ral groups have shown that the in vitro target of many aPL is not a pu
re phospholipid Ag, hut is either a complex between anionic phospholip
id and the plasma protein beta(2)-glycoprotein I (beta 2GPI) or the pr
otein beta 2GPI alone. Anionic phospholipids are normally absent from
the extracellular surface of cell membranes but redistribute from the
inner to the outer leaflet during apoptosis. We show that aPL bind spe
cifically to apoptotic, but not viable, thymocytes, and that binding i
s dependent upon the presence of beta 2GPI. Moreover, we shaw that bet
a 2GPI binds selectively to the surface of apoptotic thymocytes to gen
erate an epitope for antiphospholipid autoantibodies. These findings s
uggest that apoptotic cells may be the natural immunogen and/or target
for aPL. Moreover, we propose that the interaction of circulating bet
a 2GPI with redistributed anionic phospholipid may itself generate a n
ovel ligand by which apoptotic cells are recognized directly for phago
cytic clearance.